Login

Boston Biotech Office, Filled 18 Months Before Completion, Shows Surging Demand

Switzerland-Based Gene Editing Firm Crispr Therapeutics Agrees to Take New Lab Space Near Seaport District
The 105 is one of the latest biotech office buildings to rise in South Boston. (Breakthrough Properties)
The 105 is one of the latest biotech office buildings to rise in South Boston. (Breakthrough Properties)
By John Doherty
CoStar News
July 28, 2020 | 8:58 P.M.

Developers of one of the latest life-sciences office buildings to spring up in and around Boston’s Seaport District have landed a tenant 18 months before the project’s expected finish, reflecting demand in the nation's largest biotech region.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE